Glenmede Trust Company »

United Therapeutics Corporation shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2008-03-31 $236k 2.7k 86.67
2007-12-31 $257k 4.7k 54.22
2007-03-31 $254k 4.7k 53.59
2006-12-31 $257k 4.7k 54.22

More positions owned by Glenmede Trust Company

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Oracle Corporation (ORCL)
Home Depot (HD)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Small Cp Etf (VB)
Procter & Gamble Company (PG)

View all positions for Glenmede Trust Company

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Geode Capital Management
FMR
LSV Asset Management
AQR Capital Management
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Pacer Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation